









市场行情
/
股票
/
nasdaq-mreo
/

Mereo BioPharma Group PLC

MREO

1.870USD

+0.030+1.63%

收盘 11/28, 13:00（美东）报价延迟15分钟

1.49B总市值

亏损市盈率 TTM



Mereo BioPharma Group PLC

1.870

+0.030+1.63%

概览公司财务分析

概览

公司

财务

分析

财报

利润表

资产负债表

现金流量表

您可以在这里找到Mereo BioPharma Group PLC的年度或季度收入报告，以深入了解Mereo BioPharma Group PLC的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

FY2018H1

FY2017H2

FY2017H1

FY2016H2

FY2016H1

营业总收入

--0.00

--500.00K

----

--0.00

--8.79M

--0.00

-100.00%0.00

--0.00

--50.59M

----

营业收入

--0.00

--500.00K

----

--0.00

--8.79M

--0.00

-100.00%0.00

--0.00

--50.59M

----

主营业务成本

--0.00

--132.00K

----

--0.00

762.50%3.03M

-119.76%-685.80K

-101.82%-456.75K

---312.07K

--25.16M

----

营业费用

6.85%10.02M

-14.16%11.00M

13.15%11.20M

--15.28M

--9.37M

--12.81M

--9.90M

-13.32%24.53M

-9.56%25.55M

-44.37%28.30M

3.64%28.25M

141.93%50.87M

2.41%27.26M

-13.67%21.03M

24.58%26.62M

-1.37%24.36M

-14.02%21.37M

-25.77%24.70M

1.01%24.85M

37.28%33.27M

--24.60M

--24.23M

研发费用

34.70%4.27M

8.63%5.37M

-1.60%3.93M

--8.82M

--3.17M

--4.95M

--3.99M

-43.68%9.73M

-26.79%13.67M

26.40%17.29M

81.74%18.67M

28.03%13.68M

-30.22%10.27M

-30.69%10.68M

-3.91%14.72M

3.19%15.41M

-11.93%15.32M

-44.54%14.93M

1.39%17.40M

68.91%26.93M

--17.16M

--15.94M

折旧摊销及损耗

-86.17%39.00K

-36.96%162.00K

-1.82%270.00K

--274.00K

--282.00K

--257.00K

--275.00K

-11.98%497.96K

-34.36%341.72K

56.84%565.75K

-31.38%520.57K

-71.87%360.71K

-41.23%758.62K

36.95%1.28M

5567.58%1.29M

3273.35%936.48K

-7.12%22.78K

26.33%27.76K

14.72%24.52K

-7.93%21.97K

--21.38K

--23.87K

其他营业费用

---300.00K

----

营业利润

-6.85%-10.02M

18.07%-10.50M

-13.15%-11.20M

---15.28M

---9.37M

---12.81M

---9.90M

44.37%-15.74M

9.56%-25.55M

-9899.49%-28.30M

-3.64%-28.25M

98.65%-283.02K

-2.41%-27.26M

13.67%-21.03M

-24.58%-26.62M

1.37%-24.36M

14.02%-21.37M

25.77%-24.70M

-1.01%-24.85M

-37.28%-33.27M

---24.60M

---24.23M

净非营业利息收入（费用）

利息收入

-48.73%504.00K

5.37%589.00K

6.81%659.00K

--881.00K

--983.00K

--559.00K

--617.00K

201.99%677.92K

--614.17K

16080.75%224.48K

-100.00%0.00

-97.18%1.39K

410.22%1.54M

-72.27%49.13K

50.16%302.23K

-14.91%177.15K

--201.27K

-17.01%208.20K

----

1890.24%250.89K

--237.87K

--12.61K

利息费用

-92.07%28.00K

-92.75%24.00K

-41.94%180.00K

--375.00K

--353.00K

--331.00K

--310.00K

-38.77%1.33M

-45.47%1.40M

-17.17%2.18M

-57.27%2.56M

-25.74%2.63M

133.02%5.99M

33.36%3.54M

-10.49%2.57M

21.80%2.66M

371.29%2.87M

--2.18M

--609.54K

----

出售证券收益

129.15%1.87M

-17280.65%-5.33M

-551.06%-2.77M

---4.57M

---6.42M

--31.00K

--613.00K

-225.93%-2.29M

-300.53%-434.50K

196.56%1.82M

112.31%216.68K

-137.55%-1.89M

-377.78%-1.76M

-208.43%-793.67K

624.77%633.63K

-479.68%-257.32K

73.37%-120.75K

105.18%67.77K

-115.70%-453.47K

---1.31M

--2.89M

----

特殊收入（费用）

432.20%196.00K

-46.38%-101.00K

192.86%416.00K

--157.00K

---59.00K

---69.00K

---448.00K

-71.35%449.89K

-77.87%7.74M

-92.12%1.57M

124.41%34.99M

29943.75%19.93M

-30035740.79%-143.36M

-102.84%-66.77K

-100.05%-477.31

--2.35M

--926.57K

----

-固定资产出售收益

----

-100.00%0.00

--0.00

-72.57%153.99K

100.00%0.00

--561.46K

---14.24M

----

--0.00

----

其他非经营性收入（费用）

97.35%446.00K

101.90%745.00K

-61.22%185.00K

--576.00K

--226.00K

--369.00K

--477.00K

235.45%3.53M

--0.00

--1.05M

----

--123.59M

-20322.42%-119.24M

----

--589.64K

----

税前利润

53.18%-7.02M

-19.27%-14.62M

-43.97%-12.89M

---7.05M

---15.00M

---12.26M

---8.95M

43.00%-14.71M

-518.34%-19.02M

-270.63%-25.81M

108.63%4.55M

109.52%15.13M

-86.46%-52.68M

-557.61%-158.86M

-21.61%-28.26M

9.19%-24.16M

10.34%-23.23M

22.50%-26.60M

-20.67%-25.91M

-41.72%-34.33M

---21.48M

---24.22M

所得税

--0.00

-17.22%-1.12M

-137.09%-1.36M

41.94%-953.72K

310.29%3.68M

12.02%-1.64M

63.59%-1.75M

41.28%-1.87M

-27.51%-4.81M

2.19%-3.18M

20.71%-3.77M

43.15%-3.25M

-17.82%-4.75M

-83.75%-5.72M

---4.03M

---3.11M

除税后利润

53.18%-7.02M

-19.27%-14.62M

-43.97%-12.89M

---7.05M

---15.00M

---12.26M

---8.95M

45.31%-13.60M

-2134.31%-17.66M

-248.23%-24.86M

101.70%868.07K

110.68%16.77M

-117.20%-50.93M

-648.39%-156.99M

-20.47%-23.45M

10.16%-20.98M

8.02%-19.47M

18.38%-23.35M

-21.33%-21.16M

-35.52%-28.61M

---17.44M

---21.11M

持续经营利润

53.18%-7.02M

-19.27%-14.62M

-43.97%-12.89M

---7.05M

---15.00M

---12.26M

---8.95M

45.31%-13.60M

-2134.31%-17.66M

-248.23%-24.86M

101.70%868.07K

110.68%16.77M

-117.20%-50.93M

-648.39%-156.99M

-20.47%-23.45M

10.16%-20.98M

8.02%-19.47M

18.38%-23.35M

-21.33%-21.16M

-35.52%-28.61M

---17.44M

---21.11M

归属于母公司的净利润

53.18%-7.02M

-19.27%-14.62M

-43.97%-12.89M

---7.05M

---15.00M

---12.26M

---8.95M

45.31%-13.60M

-2134.31%-17.66M

-248.23%-24.86M

101.70%868.07K

110.68%16.77M

-117.20%-50.93M

-648.39%-156.99M

-20.47%-23.45M

10.16%-20.98M

8.02%-19.47M

18.38%-23.35M

-21.33%-21.16M

-35.52%-28.61M

---17.44M

---21.11M

归属于普通股东的净利润

53.18%-7.02M

-19.27%-14.62M

-43.97%-12.89M

---7.05M

---15.00M

---12.26M

---8.95M

45.31%-13.60M

-2134.31%-17.66M

-248.23%-24.86M

101.70%868.07K

110.68%16.77M

-117.20%-50.93M

-648.39%-156.99M

-20.47%-23.45M

10.16%-20.98M

8.02%-19.47M

18.38%-23.35M

-21.33%-21.16M

-35.52%-28.61M

---17.44M

---21.11M

基本每股收益

54.93%-0.01

-6.16%-0.02

-28.56%-0.02

---0.01

---0.02

---0.01

49.07%-0.02

-1930.32%-0.03

-225.54%-0.04

101.03%0.00

102.56%0.03

32.65%-0.15

-365.01%-1.32

18.41%-0.22

13.38%-0.28

8.51%-0.27

22.84%-0.33

-10.80%-0.30

49.77%-0.43

---0.27

---0.85

稀释每股收益

54.93%-0.01

-6.16%-0.02

-28.56%-0.02

---0.01

---0.02

---0.01

49.07%-0.02

-1930.32%-0.03

-237.81%-0.04

101.03%0.00

102.34%0.03

32.65%-0.15

-365.01%-1.32

18.41%-0.22

13.38%-0.28

8.51%-0.27

22.84%-0.33

-10.80%-0.30

49.77%-0.43

---0.27

---0.85

每股派息

----

--0.00

----

--0.00

货币单位

USD

审计意见

常见问题

什么是收入表？



收入表通常被称为损益表（P&L），它汇总了一家公司在特定会计期间的收入、费用、收益和损失。

KeyAI

